Indivior Pharmaceuticals, Inc. INDV Ratios & Valuation
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 81.3%+1.1pp | 80.2%-0.6pp | 80.8%-1.3pp | 82.1%+2.4pp | 79.8%-0.8pp | |
| Operating margin | 25.8%+4.7pp | 21.1%+1.9pp | 19.2%+0.6pp | 18.7%+16.2pp | 2.5%-0.7pp | |
| Net margin | 19.4%+2.6pp | 16.9%+6.0pp | 10.8%+1.6pp | 9.2%+9.8pp | -0.6%-1.2pp | |
| Liquidity | ||||||
| Current ratio | 0.9×+0.1× | 0.7×-0.2× | 1×— | —— | —— | |
| Leverage | ||||||
| Net debt / EBITDA | 1×+0.4× | 0.6×+0.9× | -0.4×— | —— | —— | |
| Per Share | ||||||
| Book value per share | -$1.12-45.8% | -$0.77+52.3% | -$1.60+21.3% | -$2.04+10.5% | -$2.28+10.0% | |
| Valuation | ||||||
| Market capitalization | $3.72B-17.2% | $4.49B+49.1% | $3.01B+73.2% | $1.74B+46.2% | $1.19B-23.5% | |
| Price / earnings | 14.8×— | —— | —— | —— | —— | |
| Price / sales | 2.9×-0.7× | 3.6×+1.1× | 2.5×+1.1× | 1.5×+0.5× | 1×-0.3× | |
| EV / EBITDA | 11.8×-5.2× | 17.1×+4.9× | 12.2×— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Indivior Pharmaceuticals, Inc. 's profit margins?
- Indivior Pharmaceuticals, Inc. (INDV) runs a 81.3% gross margin and a 25.8% operating margin, with a 19.4% net margin.
- Where do Indivior Pharmaceuticals, Inc. 's ratios come from?
- Every ratio is computed from Indivior Pharmaceuticals, Inc. 's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.